Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2025-11-05 00:00:00 ET · period of report 2025-10-31 · accession 0001628280-25-049659 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-05 | 2025-11-03 | SRTA | Tomkiel Melissa M. | GC, Co-CEO, Dir | F - Tax | $5.03 | -106.7K | 1.37M | -7% | -$536.5K | |
| 2025-11-05 | 2025-10-31 | SRTA | Tomkiel Melissa M. | GC, Co-CEO, Dir | A - Grant | $0.00 | +208.9K | 1.48M | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2025-11-03 | F | D | 106,659 | $5.03 | 1,372,642 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. |
| 2 | Common | Class A common stock, $0.0001 par value per share | 2025-10-31 | A | A | 208,929 | $0.00 | 1,479,301 | D | — | — | (F1) Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. |